SPY411.45-1.41 -0.34%
DIA337.53+0.74 0.22%
IXIC13,857.84-138.26 -0.99%

BRIEF-GlaxoSmithKline Says Charlie Bancroft Succeeded Judy Lewent As Chair Of Audit & Risk Committee

· 03/17/2021 14:40
BRIEF-GlaxoSmithKline Says Charlie Bancroft Succeeded Judy Lewent As Chair Of Audit & Risk Committee

- GlaxoSmithKline PLC GSK.L:

  • GLAXOSMITHKLINE PLC - CHAIR OF AUDIT & RISK COMMITTEE

  • GSK - CHARLIE BANCROFT SUCCEEDED MS JUDY LEWENT AS CHAIR OF COMPANY'S AUDIT & RISK COMMITTEE ON 13 MARCH 2021

Source text for Eikon: ID:nRSQ6312Sa

Further company coverage: GSK.L


((Reuters.Briefs@thomsonreuters.com;))